Lung Cancer Educational 3-Part Webinar Series
Image For Activity Cover
Availability
On-Demand
Access expires on 06/30/2024
Credit Offered
No Credit Offered
Webinar # 1:
Title: What is biomarker testing for advanced lung cancer and why is it important?

Description: Introduction to biomarker testing and NSCLC. Define biomarker testing, comprehensive testing, provide examples of therapies and local/metastatic indications for use based on trials/FDA approvals early and advanced stage, and illustrate improved outcomes.

Moderator:

Adam H. Fox, MD MS

Assistant Professor of Medicine

Division of Pulmonary and Critical Care Medicine

Medical University of South Carolina

Charleston, SC

Speaker: Bruce Johnson, MD

Institute Physician, Dana-Farber Cancer Institute

Professor of Medicine, Harvard Medical School

Webinar #2:
Title: Tissue is the issue: Using EBUS to acquire and process tissue for biomarker testing for advanced lung cancer

Description: Best practices for balancing diagnosis, staging, and tissue for testing. Role of EBUS and biomarker testing. Cover success rates reported in literature for different biopsy modalities. Role of ROSE, cover special scenarios (effusions, bone metes, brain mets, etc.) Considerations for QNS results: ct-DNA, re-biopsy.

Moderator:
Gerard A. Silvestri, MD MS
Hillenbrand Professor of Thoracic Oncology
Senior Vice-Chair of Faculty Development
Department of Medicine
Medical University of South Carolina
Charleston, SC

Speaker:

Nicholas J. Pastis MD

Professor of Medicine

Division of Pulmonary and Critical Care Medicine

The Ohio State University

Columbus, OH

 
Webinar 3:
Title: Establishing a program to perform lung cancer biomarker testing: Shortening the time from patient presentation to treatment

Description: Describe metrics of success/best practices and collaborations for biomarker testing programs. Dr. Sholl will cover tissue handling and pathology perspectives on turnaround time. Dr. Fox will cover reflex testing and multi-disciplinary coordination to improve turnaround time as well as the role of biomarker testing for earlier stages of lung cancer.

Moderator:

Gerard A. Silvestri, MD MS
Hillenbrand Professor of Thoracic Oncology
Senior Vice-Chair of Faculty Development
Department of Medicine
Medical University of South Carolina
Charleston, SC

Speakers:

Lynette M. Sholl MD

Department of Pathology

Brigham and Women's Hospital

Boston, MA

Adam H. Fox, MD MS

Assistant Professor of Medicine

Division of Pulmonary and Critical Care Medicine

Medical University of South Carolina

Charleston, SC

Checklist:
Title: Enhancing NSCLC Biomarker Testing: Introducing a Practical Clinician Checklist

Description: In a live CHEST webinar, Gerard A. Silvestri, MD, MS, and Adam H. Fox, MD, MS, will unveil a new clinician checklist designed to enhance biomarker testing for patients with non-small cell lung cancer (NSCLC). This informative session will delve into the methodology employed to tackle practice gaps in tissue sampling, processing/testing, and interdisciplinary coordination. Learn how to leverage this practical checklist to improve patient care and outcomes, and discover ways to actively participate in quality improvement initiatives.

© 2023 | American College of Chest Physicians®

Android App Download IOS App Download Powered By